Search

Your search keyword '"Barysheva O"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Barysheva O" Remove constraint Author: "Barysheva O"
46 results on '"Barysheva O"'

Search Results

1. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

4. Consensus on controversial issues of the surgery for Crohn’s disease by Delphi method

5. Newly diagnosed diseases and the frequency of their occurrence in patients after a new coronavirus infection. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)

6. Ulcerative colitis (K51), adults

7. The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries

9. Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis

10. Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis

11. Clinical features of post-COVID period. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)

13. Lipid profile in hospitalized patients with COVID-19 depending on the outcome of its acute phase: data from the international registry "Dynamics analysis of comorbidities in SARS-CoV-2 infection survivors"

20. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

21. The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

22. Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial

23. Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease

39. Formation of soot in the disposal of municipal solid waste

40. High-temperature processing of municipal solid waste

41. Forecasting of an output of eco toxicants at thermal decomposition of chemical fuel

42. DICER and DROSHA gene expression in peripheral mononuclear blood cells from rheumatoid arthritis patients under methotrexate therapy.

43. [Subpopulations of Regulatory T-lymphocytes in the Peripheral Blood of Patients with Rheumatoid Arthritis].

44. [A CASE OF SEVERE AMLODIPINE POISONING].

45. Temperature-regulated formation of mycelial mat-like biofilms by Legionella pneumophila.

46. [Administration of various dosages of retard isosorbide-5-mononitrate in patients with stable angina pectoris on combined therapy].

Catalog

Books, media, physical & digital resources